PREDIAGNOSTIC PROSTATE-SPECIFIC ANTIGEN KINETICS ARE NOT ASSOCIATED WITH THE RISK OF PROGRESSION IN PROSTATE CANCER PATIENTS MANAGED WITH ACTIVE SURVEILLANCE

被引:0
|
作者
Iremashvili, Viacheslav
Barney, Shane
Manoharan, Murugesan
Kava, Bruce
Parekh, Dipen J.
Punnen, Sanoj
机构
来源
JOURNAL OF UROLOGY | 2016年 / 195卷 / 04期
关键词
D O I
10.1016/j.juro.2016.02.2825
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
PD08-09
引用
收藏
页码:E231 / E232
页数:2
相关论文
共 50 条
  • [1] Prediagnostic prostate-specific antigen kinetics and the risk of biopsy progression in active surveillance patients
    Iremashvili, Viacheslav
    Barney, Shane L.
    Manoharan, Murugesan
    Kava, Bruce R.
    Parekh, Dipen J.
    Punnen, Sanoj
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (04) : 313 - 317
  • [2] Editorial Comment to Prediagnostic prostate-specific antigen kinetics and the risk of biopsy progression in active surveillance patients
    Mitsuzuka, Koji
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (04) : 317 - 318
  • [3] PROSTATE-SPECIFIC ANTIGEN KINETICS AND BIOPSY PROGRESSION IN PATIENTS MANAGED BY ACTIVE SURVEILLANCE
    Iremashvili, Viacheslav
    Manoharan, Murugesan
    Lokeshwar, Soum
    Rosenber, Daniel L.
    Pan, David
    Soloway, Mark S.
    [J]. JOURNAL OF UROLOGY, 2012, 187 (04): : E847 - E848
  • [4] Value of Prostate-Specific Antigen Kinetics in Patients with Low-Risk Prostate Cancer under Active Surveillance
    Fernandez-Anguita, Pedro Jesus
    Ventosa-Puig, Marta
    Diaz-de-Mera-Sanchez-Migallon, Inmaculada
    Legido-Gomez, Oscar
    Carrion-Lopez, Pedro
    Martinez-Ruiz, Jesus
    Salinas-Sanchez, Antonio Santiago
    Gimenez-Bachs, Jose Miguel
    [J]. UROLOGIA INTERNATIONALIS, 2023, 107 (07) : 706 - 712
  • [5] Comprehensive analysis of post-diagnostic prostate-specific antigen kinetics as predictor of a prostate cancer progression in active surveillance patients
    Iremashvili, Viacheslav
    Manoharan, Murugesan
    Lokeshwar, Soum D.
    Rosenberg, Daniel L.
    Pan, David
    Soloway, Mark S.
    [J]. BJU INTERNATIONAL, 2013, 111 (03) : 396 - 403
  • [6] VARIATION OF SERUM PROSTATE-SPECIFIC ANTIGEN LEVELS FOR MEN WITH PROSTATE CANCER MANAGED WITH ACTIVE SURVEILLANCE
    Ehdaie, Behfar
    Poon, Bing Ying
    Sjoberg, Daniel
    Vickers, Andrew
    Sternberg, Itay
    Laudone, Vincent
    Touijer, Karim
    Eastham, James
    Scardino, Peter
    [J]. JOURNAL OF UROLOGY, 2014, 191 (04): : E859 - E860
  • [7] Is It Time to Revisit the Role of Prostate-specific Antigen Kinetics in Active Surveillance for Prostate Cancer?
    Iremashvili, Viacheslav
    Kava, Bruce R.
    Manoharan, Murugesan
    Parekh, Dipen J.
    Punnen, Sanoj
    [J]. UROLOGY, 2016, 95 : 139 - 144
  • [8] Variation in serum prostate-specific antigen levels in men with prostate cancer managed with active surveillance
    Ehdaie, Behfar
    Poon, Bing Ying
    Sjoberg, Daniel D.
    Recabal, Pedro
    Laudone, Vincent
    Touijer, Karim
    Eastham, James
    Scardino, Peter T.
    [J]. BJU INTERNATIONAL, 2016, 118 (04) : 535 - 540
  • [9] Prostate-specific antigen doubling time as a progression criterion in an active surveillance programme for patients with localized prostate cancer
    Thomsen, Frederik Birkebaek
    Christensen, Ib Jarle
    Brasso, Klaus
    Roder, Martin Andreas
    Iversen, Peter
    [J]. BJU INTERNATIONAL, 2014, 113 (5B) : E98 - E105
  • [10] Refined Analysis of Prostate-specific Antigen Kinetics to Predict Prostate Cancer Active Surveillance Outcomes
    Cooperberg, Matthew R.
    Brooks, James D.
    Faino, Anna, V
    Newcomb, Lisa F.
    Kearns, James T.
    Carroll, Peter R.
    Dash, Atreya
    Etzioni, Ruth
    Fabrizio, Michael D.
    Gleave, Martin E.
    Morgan, Todd M.
    Nelson, Peter S.
    Thompson, Ian M.
    Wagner, Andrew A.
    Lin, Daniel W.
    Zheng, Yingye
    [J]. EUROPEAN UROLOGY, 2018, 74 (02) : 211 - 217